QA: Chinook Therapeutics INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001435049_2022_Chinook_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001435049, Chinook Therapeutics INC

  xvar xval
0 AssetsCurrent 300,639,000
1 IntangibleAssetsNetIncludingGoodwill 26,126,000
2 PropertyPlantAndEquipmentNet 18,935,000
3 remainder_Assets 218,103,000
4 LiabilitiesCurrent 40,085,000
5 LiabilitiesNoncurrent 39,589,000
6 remainder_Liabilities 30,486,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 31,783,815
9 ResearchAndDevelopmentExpense 99,685,291
10 remainder_Expenses 30,641,717
11 remainder_Revenues 42,009,117
12 remainder_NetIncome 3,240,361
13 remainder_ComprehensiveNetIncome -31,011
  yvar yval
0 Assets 563,803,000
1 Liabilities 110,160,000
2 Expenses 162,110,823
3 Revenues 42,009,117
4 StockholdersEquity 453,643,000
5 NetIncome -116,861,345
6 ComprehensiveNetIncome -116,876,850
7 BaseVar 440,677,156
8 EconomicCapitalRatiobeforeLimitedLiability 2.59
9 EconomicCapitalRatio 3.41

Edgar->Model Mapping

Feature Distribution

Change over Time